Aliso Viejo, CA – January 6, 2015 – Ambry Genetics (“Ambry”) announces the launch of powerful cardiovascular genetic testing panels for inherited cardiomyopathies and arrhythmias. These feature an intuitive, tiered approach to testing for hypertrophic cardiomyopathy, long QT syndrome, and Brugada syndrome. Sudden death may be the first and only symptom of some of these…

Aliso Viejo, Calif., November 13, 2014 Ambry Genetics announces the publication of its clinical exome sequencing cohort data, released November 13, 2014 in Genetics in Medicine, the official peer-reviewed journal of the American College of Medical Genetics and Genomics. This marks the announcement of the highest detection rate for clinical exome sequencing available on the commercial market today.…

Aliso Viejo, Calif., ? Ambry Genetics and researchers from Memorial Sloan Kettering Cancer Center, Mayo Clinic, Abramson Cancer Center of the University of Pennsylvania, Dana-Farber Cancer Institute and other diagnostic testing laboratories announced a research partnership aimed to recognize the significance of mutations and variants found by multi-gene testing for hereditary cancer. Participants in the…

Aliso Viejo, Calif., June 26, 2014? Today, Ambry Genetics and the Mauli Ola Foundation (MOF) announced the Battle for the Breasts, an online surf video contest, powered by Surfline. The goal of this three-month event is to increase public awareness of breast cancer and the importance of early detection and screening. Sixteen randomly selected cancer…

DMG Productions explores advancements in genetics and genomics. Aliso Viejo, CA —Ambry Genetics announced that they will be featured in an upcoming episode of Innovations with Ed Begley, Jr., airing later this year 2014, via Discovery Channel. Dates and show times TBA. Built by scientists, genetic counselors, and physicians, Ambry Genetics is dedicated to providing…

Researchers Suggest Payors and Clinicians Should Choose BRCA Labs that Behave Ethically, Make Data Available NEW YORK (GenomeWeb) – Patients who receive genetic tests for cancer risks should be able to trust that the labs conducting their tests behave ethically, and that the genetic data these labs generate will be made publicly available, three genetics…

ALISO VIEJO, Calif. — Ambry Genetics announced the publication of the highly anticipated results on the first 2000 patients tested, in the journal Genetics in Medicine, supporting the clinical adoption of multigene cancer panels in the diagnosis of hereditary cancer predisposition. The study evaluated the first 2,079 patients who underwent Ambry’s hereditary cancer multigene panel…

Aliso Viejo, CA – March 26, 2014 – Ambry Genetics (“Ambry”) announces the launch of ExomeNextTM and ExomeNext-RapidTM at the American College of Medical Genetics (ACMG) conference today in Nashville. The new assays feature lower turn-around-times, lower pricing, more comprehensive coverage and a new expedited option called ExomeNext-RapidTM for severe clinical cases that require an immediate…

Aliso Viejo, Calif. – March 10, 2014 – Ambry Genetics (“Ambry”), the worldwide leader in hereditary cancer testing, announced today that it has successfully defended itself against the preliminary injunction motion filed on July 9, 2013 by Myriad Genetics (“Myriad”) and other plaintiffs in University of Utah Research Foundation et al. v. Ambry Genetics Corporation, Case…